This Act may be cited as the “The Newborn Screening Saves Lives Reauthorization Act of 2019”.

(a) Improved newborn and child screening for heritable disorders.—Section 1109(a)(3) of the Public Health Service Act (42 U.S.C. 300b–8(a)(3)) is amended—

(1) by striking “develop and deliver educational programs (at appropriate literacy levels)” and inserting “develop, deliver, and assess the impact of educational programs (with varying levels of information and at appropriate literacy levels)”; and

(2) by striking “and specialty services” and inserting “specialty services, research-related pilot studies, and long-term care”.

(b) Extension of advisory committee on heritable disorders in newborns and children.—Section 1111(g) of the Public Health Service Act (42 U.S.C. 300b–10(g)) is amended by striking “2019” each place it appears and inserting “2024”.

(c) Technical amendments.—Title XI of the Public Health Service Act (42 U.S.C. 300b–1 et seq.) is amended—

(1) in the section heading of section 1110, by striking “Followup” and inserting “Follow-Up”;

(2) in sections 1109, 1110, and 1111, by striking “followup” each place such term appears and inserting “follow-up”; and

(3) in paragraphs (1) and (2) of section 1110(b), by inserting “(including long-term follow-up)” before “, or specialty”.

(d) Clearinghouse of newborn screening information.—Subsection (c) of section 1112 of the Public Health Service Act (42 U.S.C. 300b–11) is amended to read as follows:

“(c) Nonduplication.—In carrying out activities under this section, the Secretary shall ensure that such activities minimize duplication and complement other existing Federal newborn screening-related information-sharing activities.”.

(e) Laboratory quality and surveillance.—Section 1113 of the Public Health Service Act (42 U.S.C. 300b–12) is amended—

(1) in subsection (a)—

(A) in paragraph (1)—

(i) by striking “performance evaluation services” and inserting “development of new screening tests”; and

(ii) by striking “; and” and inserting a semicolon;

(B) in paragraph (2)—

(i) by striking “performance test materials” and inserting “test performance materials”; and

(ii) by striking the period and inserting “; and”; and

(C) by adding at the end the following:

“(3) performance evaluation services to enhance disease detection, including the development of tools and resources to improve data analysis, interpretation of test results, and dissemination of laboratory best practices.”; and

(2) in subsection (b)—

(A) in paragraph (1), by striking “; and” and inserting a semicolon;

(B) in paragraph (2), by striking the period and inserting “; and”; and

(C) by adding at the end, the following:

“(3) by assisting States, as appropriate, in assessing and conducting long-term follow-up and assessing long-term outcomes.”.

(f) Hunter Kelly research program.—Section 1116(a)(1)(D) of the Public Health Service Act (42 U.S.C. 300b–15(a)(1)(D)) is amended—

(1) by inserting “, or with a high probability of being recommend by,” after “recommended by”; and

(2) by striking “to ensure that screenings are ready for nationwide implementation” and inserting “, which may include those conditions that have been nominated pursuant to section 1111, to ensure that screening technologies are piloted and ready for implementation”.

(g) Authorization of appropriations.—Section 1117 of the Public Health Service Act (42 U.S.C. 300b–16) is amended—

(1) in paragraph (1), by striking “$11,900,000 for each of fiscal years 2015 through 2019” and inserting “$16,383,000 for each of fiscal years 2020 through 2024”; and

(2) in paragraph (2), by striking “$8,000,000 for each of fiscal years 2015 through 2019” and inserting “$17,250,000 for each of fiscal years 2020 through 2024”.

(h) Technical assistance.—The Secretary shall publish on the internet website of the Department of Health and Human Services, information regarding the process for obtaining technical assistance for submitting nominations to the recommended uniform screening panel.

(i) Report on the modernization of newborn screening.—

(1) IN GENERAL.—The Secretary of Health and Human Services shall, directly or through a contract, conduct an assessment of each of the following:

(A) The uniform screening panel review and recommendation processes, including an assessment of factors that impact decisions to add new conditions to the uniform screening panel and challenges associated with newly nominated conditions, including rare diseases with late onset variants.

(B) Strategies to support implementation of uniform screening panel recommendations.

(C) Opportunities to improve newborn screening research, such as piloting the screening of multiple conditions in a single test and optimizing the capacity for such research.

(D) Technologies that would improve screening, including technologies that identify multiple, related disorders in a single test.

(E) Methods to improve public health surveillance, timeliness of diagnosis, and short- and long-term follow-up for infants identified through newborn screening.

(F) Strategies to improve communication with the public and stakeholders in order to promote understanding and knowledge of the newborn screening system.

(G) The quality of data on disease prevalence for screened conditions.

(H) The effect of newborn screening on the outcomes of those identified as newborns through such screenings.

(2) REPORT.—Not later than 2 years after the date of enactment of this Act, the Secretary of Health and Human Services shall submit, to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives, a report containing the results of the assessment and recommendations to improve processes described in paragraph (1).